Fentanyl uptake by the scimed membrane oxygenator by Rosen, David A. et al.
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David Rosen, MD, Kathleen Rosen, MD, Bruce Davidson, and Lynn Broadman, MD 
With the initiation of cardiopulmonary bypass (CPB), 
using a membrane oxygenator, the drop in circulat- 
ing fentanyl concentration is greater than can be 
attributed to dilution alone. This study examined the 
Scimed brand (2A-BOO) membrane oxygenator as a 
site of fentanyl binding. Initial experiments used an 
assembled CPB circuit. Subsequent dissection and 
analysis of the oxygenator revealed that the silicone- 
based membrane sheets were the primary site of 
fentanyl binding. The silicone-containing waterproof 
wrapper was also responsible for 1% to 2% of 
fentanyl binding. Binding of fentanyl to the Scimed 
membrane oxygenator occurs at a rapid rate and 
continues until the membrane has taken up 130 
ng/cm’ of membrane surface area. The interaction is 
complete by 15 to 30 minutes if suprasaturated 
concentrations are used. Samples of membrane 
material with a surface area of 1 cm’ were also 
studied. Isolated membrane squares in a nonmoving 
prime solution required two hours for saturation at 
the same fentanyl concentrations as the intact mem- 
brane with circulating prime. Introduction of motion 
I N RECENT YEARS, the use of high-dose narcotic anesthesia for cardiac surgery has 
become very popular. Fentanyl is a commonly 
selected agent because of its minimal cardiovas- 
cular side effects. The pharmacokinetics of fen- 
tanyl have been studied in both adults and chil- 
dren and are well understood in the nonbypass 
setting.‘” Use of the cardiopulmonary bypass 
(CPB) circuit is assumed to alter fentanyl kinet- 
ics if only by dilution and expansion of the 
circulating blood volume. Many studies describe 
this phenomenon.3-7 Koren et al were the first to 
note that the decrease in fentanyl plasma levels 
upon initiation of CPB was much greater than 
was predicted from the increased volume of 
distribution alone.“‘,’ They demonstrated that 
therapeutic fentanyl concentrations (>20 ng/ 
mL) rapidly fell to low subtherapeutic levels 
upon initiation of bypass using a silicone-based 
membrane oxygenator. This group postulated 
that the site of fentanyl absorption was the 
membrane oxygenator. 3,5,7 They also showed no 
significant fentanyl absorption by the PVC tub- 
ing in their circuit. Skacel et al showed that 
absorption in the bypass circuit also occurs when 
a bubble oxygenator is used.’ Unfortunately, 
because many early clinical studies have failed to 
identify the oxygenator brand and type, compari- 
sons are difficult. Maintenance of anesthesia and 
to the priming solution accelerated the rate of fen- 
tanyl binding by the isolated membrane squares to a 
rate similar to the intact membrane. Motion also 
provided results similar to those previously reported 
using different analysis techniques. Therefore, this 
method of studying fentanyl-membrane interactions 
using samples of membrane and tritiated fentanyl is 
a valid model for the intact membrane oxygenator in 
the assembled bypass circuit. In addition to solution 
movement, fentanyl concentration of the priming 
solution was also found to affect the rate of fentanyl 
uptake. When fentanyl concentrations were used 
which were insufficient to achieve saturation of the 
membrane (10 ng/mL and 20 ng/mL). the rate of 
uptake was slowed. Binding of all available fentanyl 
under these conditions occurred within three hours. 
There is potential modification of this interaction by 
several clinically relevant factors. including tempera- 
ture, pH, protein content of prime solution, and other 
drugs. These areas require further study before the 
saturation data are applied to clinical practice. 
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therapeutic fentanyl levels throughout the surgi- 
cal procedure, including the bypass period, is 
optimal for the patient undergoing cardiac sur- 
gery. Plasma fentanyl levels >20 ng/mL are 
required to prevent the stress response to surgery. 
Previous clinical studies have not been able to 
achieve this goal. It is necessary to have a better 
understanding of fentanyl pharmacokinetics in 
the CPB system before approaching this clinical 
dilemma. The purpose of this study was twofold. 
The first was to study the interaction of an intact 
CPB circuit using a membrane oxygenator and 
fentanyl, including the possible determination of 
a saturation point. The second goal was to 
develop and verify an experimental method, 
which is performed in a small, material-conserv- 
ing model and is an accurate representation of 
the entire membrane within the CPB circuit. 
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METHODS 
Intact Cardiopulmonary Bypass Studies 
dissected, and two samples of the silicone outer sheet and six 
samples of the membrane itself were removed for fentanyl 
analysis. 
A CPB circuit was assembled using 5 in PVC tubing, 
a bubble trap, and a 2A-800 Scimed membrane. 
Experiment 1. The CPB system was primed with 50 
pg tritiated fentanyl in 400 mL of Normosol R balanced to 
pH 7.4 to produce a fentanyl concentration of 125 ng/mL. 
Flow in the CPB circuit was maintained at 1.0 L/mm, and 
temperature was a constant 23%. At time zero, a 0.5 mL 
sample was obtained as the liquid made its first pass through 
the membrane. Then, every 15 minutes for two hours an 
additional 0.5 mL aliquot was obtained for fentanyl analysis. 
At each time interval, the fentanyl analysis was performed 
twice. At the completion of the run, the oxygenator was 
dissected and random selection of membrane squares at four 
locations and a 1 cm2 sample of the silicone wrapper were 
obtained (Fig 1). The components were analyzed for fentanyl 
by radionuclear technique. 
Isolated Membrane Studies 
Samples of membrane material from the oxygenator 
were used. Pieces of membrane 1 x 1 cm were obtained. The 
surface area of each membrane square was calculated using 
the dry weight and the known density (0.01399 g/cm*) 
supplied by the manufacturer. 
Experiment 3. Eighteen 1 x 1 cm squares of mem- 
brane oxygenator material were placed in the same vessel 
containing 5 mL of fentanyl in Normosol R solution at 23°C. 
The fentanyl concentration was 125 ng/mL. A pair of 
membrane samples was removed immediately at time zero. 
The remaining membrane squares were incubated in the 
fentanyl solution and two membrane squares were subse- 
quently removed at 15 minute intervals for two hours. 
Experiment 2. The CPB system was primed with 
300 mL of Normosol R. After debubbling, 1,100 wg of 
fentanyl was added to produce a measured fentanyl concen- 
tration of 367 ng/mL. The prime was then circulated at a 
flow of 1.0 L/min at 23OC. Aliquots of 0.5 mL of the 
circulating prime solution were obtained for fentanyl analysis 
at 30 seconds, 5 minutes, 15 minutes, and then every 15 
minutes for the next 2.75 hours. Analysis was performed in 
duplicate. As in experiment 1, the oxygenator was then 
Experiment 4. A 1 cm piece of the membrane was 
placed in each of 32 test tubes. Two additional test tubes 
containing no membrane were run concurrently as a control. 
One milliliter of a solution containing 340 ng/mL of fentanyl 
in Normosol R was added to each tube. This fentanyl 
concentration was estimated to be greater than the saturation 
capacity of the membrane. Immediately after immersion, the 
membranes were removed in the time zero test tubes. Paired 









Fig 1. Detailed view of 6cimed oxygenator. 
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minutes. This experiment was repeated using decreasing 
fentanyl concentrations. The additional solutions studied 
contained fentanyl255,200,20, or 10 ng/mL. 
Experiment 5. A 1 cm’ membrane sample was 
placed in a tube containing 2 mL of 114 ng/mL of fentanyl in 
Normosol R solution. The solution was continuously mixed in 
a Vortex Genie mixer (Scientific Products, American Hospi- 
tal Supply, McGaw Park, IL). Ten microliter samples of the 
circulating fluid were obtained at 0,0.5, 5, 10, 15, 30,45,75 
minutes and analyzed for fentanyl content. This entire exper- 
iment was repeated in identical fashion to produce a second 
set of data points at the same time intervals. 
Fentanyl Analysis 
Each of the experiments used tritiated fentanyl to 
demonstrate the interaction of fentanyl with the membrane 
oxygenator of the CPB circuit. Analysis of fentanyl binding 
was quantitated using liquid scintillation counting. The tri- 
tiated fentanyl base was donated by Janssen Pharmaceuticals 
(IRE Institut National des Radioelements National Institut 
Voor Radio-Elementen B-6220, Fleurus, Belgium). The con- 
centration of fentanyl was 50 pg/mL. The specific activity 
was 15 Ci/mmol, yielding a radioactive concentration of 1 
mCi/mL. 
Samples were placed in 2.5 mL aquasol solution and 
then into a Beckman LS 7500 scintillation counter (Beckman 
Instruments, Fullerton, CA). The counts per minute from the 
counter samples were converted to disintegrations per minute 
(dpm) using the H# quench correction method.* The dpm 
was then mathematically manipulated as listed below to yield 
the concentration of fentanyl in the sample. 
dpm 
volume of sample 
x Total volume x 336,460 pg/mmol 
(2.22; 1012) dpm/Ci x 15 Ci/mmol 
= wg fentanyl. 
RESULTS 
Through use of a radiolabeling technique, 
the primary site of fentanyl uptake by the CPB 
apparatus was definitely identified as the mem- 
brane oxygenator. Not only the membrane mate- 
rial but also the silicone wrapper has affinity for 
fentanyl. When the membrane was dissected, 1% 
(0.5 pg) of the prime fentanyl was found on the 
silicone wrapper. In experiment 1, the intact 
membrane was responsible for a 68% decrease in 
the circulating fentanyl concentration after only 
one pass through the membrane (Table 1). After 
two hours, >92% of the initial circulating fenta- 
nyl had become bound to the oxygenator. The 
*H-Number and AQC, Beckman Instructions #015- 
555874 LS 7500 Liquid Scintillation System operating man- 
ual, pp 5-9. 
Table 1. Fentsnyl Levels From Intact Circulating 







Assumed Membrane C&&ted 
Fensnyl Uptake in F.Sntanyl 
Owgsnatw* (ne/cmZ~ Bound (%) 
-10 125 0 0 
0 40 4.3 68.5 
15 30 4.8 76.7 
30 20 5.3 84.7 
45 1B 5.4 86.8 
60 15 5.5 88.7 
75 12 5.6 90.8 
90 12 5.6 90.8 
105 10 5.8 92.7 
120 10 5.8 92.7 
*Assumed fentanyl uptake calculated by loss in fentanyl 
from the prime divided by the membrane surface area of the 
oxygenator. 
fentanyl concentration had fallen from 125 to 10 
ng/mL, with a resultant membrane uptake of 5.8 
ng/cm2. 
The behavior of the intact membrane 
exposed to a higher concentration of fentanyl was 
studied in experiment 2. Rapid fentanyl uptake 
occurred during the first 15 to 30 minutes. The 
membrane appeared to become saturated at 
- 130 ng/cm2 (Fig 2). Prior to saturation, uptake 
could be described by the formula: uptake (ng/ 
cm2) = 0.96 + 23.4 x, where x = time in minutes. 
At the end of the circulation period, random 
samples from the dissected membrane were also 
analyzed. As in experiment 1, analysis of the 
silicone wrapper revealed fentanyl binding. The 
wrapper of the 2A-800 membrane with a surface 
area of 5 12 cm2 contained 44 ng/cm2 of fentanyl. 
With a suprasaturated fentanyl solution, the 
wrapper bound s the amount of fentanyl/cm2 as 
the membrane material. Owing to the much 
smaller surface area, ~2% of fentanyl in the 
oxygenator was bound to the wrapper. By extra- 
polation, all the fentanyl that disappeared from 
the circulating prime could be accounted for 
bound to the membrane or silicone wrapper. 
The uptake of fentanyl by isolated oxygen- 
ator membrane squares is demonstrated in 
experiment 3 (Table 2). At time zero (the equiv- 
alent of one pass through the oxygenator), the 
uptake of fentanyl was 3 ng/cm2. The rate of 
decline in fentanyl concentration in the prime 
corresponding to membrane uptake was less 
rapid in experiment 3 than in experiment 1. At 
the 120 minute sample interval, neither a plateau 
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Fig 2. Uptake of intact and isolated membranes exposed to circulated and unoirculated priming solutions containing 
fentanyl in suprasaturated concentrations. 
in fentanyl uptake nor complete uptake of all 
available fentanyl had occurred. 
Experiment 4 demonstrates the conserva- 
tion of tritiated fentanyl mass in the liquid and 
solid phases (Table 3). Throughout the experi- 
ment, the total number of nanograms of fentanyl 
recovered from both the liquid and the mem- 
brane surface as assessed by liquid scintillation 
counting was 340 ng + 10%. No change in the 
fentanyl concentration was observed in the con- 
trol tubes over time. After 150 minutes, the 
membranes approached saturation with an 
uptake of 130 ng/cm*. Similar results were 
obtained with the subsequent suprasaturated 
priming solutions (Table 4) of 255 and 200 
ng/mL. The correlation between the rate of 
binding and capacity of uptake by the various 
suprasaturated fentanyl priming solutions were 
similar at r* = 0.982. The uptake over time for 
priming solutions containing a fentanyl concen- 
Table 2. Concentration of Fentanyl Bound to 18 
Membrane Squares (1 cm)* Placed in 625 ng of Fentanyl 
in 5 mL of Normosol R 
Fentanyi Bound 
to Membrane 
Time (min) b7g/cm2) 










*Two membrane samples were removed at each time 
interval, and their fentanyl concsntration was averaged. 
tration greater than that required for saturation 
is shown in Fig 3. Under these conditions, uptake 
can be predicted by the following best fit equa- 
tion: Uptake (ng/cm’) = 10.73 + 1.02 
x - 0.002 x2 where x = time (minutes). Mem- 
brane squares exposed to clinically applicable 
concentrations of tritiated fentanyl, 10 and 20 
ng/mL, were also studied in experiment 4. Incu- 
bation of membrane squares in these solutions 
resulted in uptake of all available fentanyl. In the 
10 ng/mL prime, 10 ng/cm* was achieved and in 
the 20 ng/mL prime 20 ng/cm* was achieved. 
The uptake over time for the 10 and 20 ng/mL 
subsaturated primes are shown in Fig 4. In both 
solutions, uptake of >99% of the initially avail- 
able fentanyl occurs by three hours. The propor- 
tion of fentanyl bound to the membrane com- 
pared to the amount in solution is similar for both 
Table 3. Concentration of Fentanyl in Membrane and 
Liquid Exposed to 340 ng of Fentanyi 
-he Membrane Liquid Total 
(min) Ing) M hlg) 
- 10 0 340.0 340.0 
0 6.2 299.4 305.6 
15 6.0 270.9 303.3 
30 39.1 278.8 317.9 
45 67.2 276.3 345.5 
60 55.4 286.3 341.7 
75 103.8 228.9 332.7 
90 60.9 304.2 365.1 
105 62.0 280.3 342.3 
120 103.6 250.0 353.6 
135 101.7 257.8 359.5 
150 129.5 205.3 334.8 
165 116.7 229.8 346.5 
180 130.5 233.2 363.7 
195 138.8 227.7 366.5 
210 99.9 245.9 345.8 
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Table 4. Fentanyl Uptake of Two Diierent 
Supresaturated Primes [Prime Membrane Uptake 
(ng/cm’)l 
sample. The correlation between the circulated 
isolated and intact membrane was r = 0.9 13. 
lime 255 ng/mL 200 ng/mL 
(mid Prima Prime 
- 10 0 0 
0 2.4 2.95 
15 22.8 25.5 
30 41.2 36.2 
45 52.1 47.9 
60 61.9 53.6 
75 67.7 61.5 
90 80.7 73.9 
105 89.2 70.6 
120 88.8 69.1 
135 98.4 98.0 
160 114.6 100.1 
165 116.7 98.9 
180 124.4 105.7 
195 123.7 107.8 
210 131.1 111.9 
225 114.1 116.6 
DISCUSSION 
the 10 and 20 ng/mL primes throughout the 
course of the experiment. These uptake relation- 
ships can also be described numerically: for the 
20 ng/mL solution, Uptake (ng/cm’) = 1.3 + 
0.16x to 0.00033x2. For the 10 ng/mL solution, 
Uptake (ng/cm’) = 0.63 + 0.076x to 
0.000 1 7X2. 
In experiment 5, the isolated membrane 
square was studied in a fentanyl concentration 
similar to that of experiment 3 with the simple 
addition of motion to the priming solution. Rapid 
fentanyl uptake occurred over the first 30 min- 
utes, and the membrane became saturated at 
- 130 ng/cm*. The rate of uptake in this model 
resembled that observed in the intact membrane 
For these experiments and those previously 
described by Koren et al?5*7 Scimed membrane 
oxygenators were used. Scimed brand mem- 
branes are silicone-based membranes with a non- 
porous sheetlike structure. Other currently 
available membranes are made with silicone, 
polypropylene, or other combinations of syn- 
thetic microporous materials in sheet or tubular 
structures. The behavior of other membrane 
brands should not be assumed to be similar to 
that of the Scimed membranes. The Scimed 
oxygenator has two continuous sheets of mem- 
brane wound about the central core (Fig 1). The 
oxygen interface surfaces are partitioned by a 
meshwork frame. The priming solution separates 
the other contiguous surfaces. Although the 
membrane brand was the same, the method of 
fentanyl detection was quite different in this 
study. All prior studies monitored only the disap- 
pearance of fentanyl from the prime solution and 
postulated that the membrane oxygenator was 
the site of binding. Use of tritiated fentanyl 
allowed analysis of both the prime solution and 
the oxygenator itself. The only site in the oxygen- 
ator other than the membrane material that 
contributes to the absorption of the fentanyl is 
the silicone wrapper sheet that surrounds the 
membrane to provide a watertight seal (Fig 1). 
In an intact membrane oxygenator, 1% to 2% of 
the fentanyl uptake could be attributed to bind- 
ing by the silicone wrapper. This was true for 
0 100 TIME 2bo 
(minutes) 
F-Ii 3. Uptake of isolated membrane squares exposed to uncircubted supraaaturated prime. 
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0 100 200 
TIME 
(minutes) 
Fig 4. Uptake of isolated membrane exposed to uncirculated lO- and PO-ng/mL eolutionr over time. (al 10 ng/mL. y 
- 0.6327 + 0.0764x - 1.702e - 4x’. r - 0.99: (-+-I 20 ng/mL. y - 1.3361 + 0.1661~ - 3.29oe - 4x2. r - 0.99. 
both intact membrane studies (experiments 1 
and 2), despite a threefold difference in fentanyl 
priming concentration. 
In experiment 1, study conditions used by 
Koren et al’*‘*’ were reproduced to confirm the 
efficacy of the present methods. The use of 
tritiated fentanyl to analyze the fentanyl content 
was validated as an alternative to gas chromato- 
graphic techniques which other investigators 
used. 3*5,7V8,9 Koren et al used a fentanyl concentra- 
tion of 120 ng/mL and found a 74% f 8.7% drop 
in the circulating fentanyl concentration in vitro 
using an assembled CPB circuit on first pass 
through the membrane.5 This was similar to the 
present study’s 68% first-pass reduction by the 
assembled circuit membrane using a similar 
starting concentration (125 ng/mL). 
The initial object of experiment 3 was to 
evaluate the behavior of isolated membrane 
squares in comparison to the intact membrane 
oxygenator. Although the initial fentanyl con- 
centration was similar to the intact circuit of 
experiment 1, the subsequent rate of rise of 
fentanyl concentration on the membranes was 
not. Later phases of the experiment identified 
differences in methodology, which explain this 
discrepancy. When these experiments (1 and 3) 
were performed, the saturation point of the mem- 
brane was unknown. This was subsequently 
determined. Both priming solutions contained 
fentanyl concentrations considerably below that 
necessary for saturation. In experiment 1, only 
6.2 ng of fentanyl was available per square 
centimeter of membrane as compared to 34.7 ng 
of fentanyl per square centimeter of membrane 
in experiment 3. During the 120 minute study 
period, -90% of fentanyl available was bound to 
the membrane. In addition, the rate of rise of fen- 
tanyl activity on the membrane was shown to be 
a function of the amount of fentanyl available 
when a subsaturated prime is used. Finally, 
movement of the fentanyl priming solution 
increases the rate of binding, as determined by 
experiment 5. The earlier isolated membrane 
study (experiment 3) did not use a circulating 
method. 
A similar pair of experiments studied the 
isolated membrane samples and intact mem- 
brane in the CPB circuit under conditions in 
which saturation was achieved. The saturation 
point of the silicone membrane was determined 
to be - 130 ng/cm’. This was found both in the 
intact membrane (experiment 2) in the CPB 
circuit and in the isolated membrane model 
(experiment 4) at different suprasaturated prim- 
ing concentrations. Isolated membrane fentanyl 
binding in an uncirculated suprasaturated solu- 
tion achieved equilibrium at 150 minutes. This 
point is reached more rapidly in the intact cir- 
culated circuit. Although both experimental 
systems approach an equilibrium of fentanyl 
binding at the same level, the kinetics of this 
association are not the same in the two models. 
When circulatory motion was applied to the 
isolated membrane squares (experiment 5), the 
resultant rate of uptake closely resembled the 
intact membrane circuit at full flow. The cre- 
ation of a boundary layer deficient in substrate is 
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potentially responsible for the decreased rate of 
uptake in the noncirculated isolated membrane 
studies. This also would serve to explain the 
irregularity in the slope of the absorption curve. 
An example would be the apparent fall in fen- 
tanyl uptake at 210 minutes in experiment 3 
(Table 3). The boundary layer is a recognized 
concept in membrane oxygenator dynamics, and 
elimination or minimization of this effect is 
critical to maximize the oxygenator efficien- 
cy. ‘o-‘* The boundary layer is formed because not 
all of the prime is actually in contact with the 
membrane. The fluid in immediate proximity to 
the membrane surface interacts faster than that 
farther away. Turbulence allows mixing of this 
layer effect. It is the boundary layer phenomenon 
that creates one of the primary limitations to 
transfer of gases and chemicals across the mem- 
brane. The boundary layer is minimized by the 
Scimed oxygenator structure by implanting da- 
cron fibers within the silicone sheet to provide 
surface contour. As the prime in the CPB moves 
across this surface, it creates turbulence which 
helps to minimize the boundary layer phenome- 
non. The turbulence created by a vortex mixer 
(experiment 5) is similar to the continuously 
flowing solution in the intact CPB circuit and 
minimizes the boundary layer formation sug- 
gested in earlier experimental phases. 
The membrane appears to be faster and 
more effective in binding fentanyl when supra- 
saturated concentrations are used, and the ratio 
of fentanyl concentration to membrane surface 
area is high. Comparison of the uptake formulas 
for the two subsaturated solutions indicates that 
the slope for the 20 ng/mL solution is twice that 
of the 10 ng/mL solution. Membrane samples 
exposed to a fentanyl concentration of 10 and 20 
ng/mL absorbed all available fentanyl after 210 
minutes. For all subsaturated solutions tested, 
both intact and isolated, 90% of the available 
fentanyl was membrane bound by two hours. 
Experiment 3 confirmed that the uptake of fen- 
tanyl was much greater than had been initially 
anticipated from work by Koren et a13v5*’ There- 
fore, a concentration 2.5 times that available in 
experiment 3 was used for experiments 2 and 4 in 
order to attain saturation. 
Clinical studies like that of Koren et a13’577 
have shown that even when the prebypass fen- 
tanyl levels were >20 ng/mL, the initiation of 
hypothermic bypass resulted in a rapid fall far 
below 20 ng/mL. The levels continued to be low 
throughout the bypass period.’ Skacel et al used 
a circuit with a bubble oxygenator.* Many bub- 
ble oxygenators use a synthetic mesh for debub- 
bling of oxygenated blood, which would also be 
predicted to remove circulating fentanyl. They 
also used silicone-containing pump head tubing. 
Skacel et al’ postulated the binding mechanism 
to be pH-dependent hydrophobic uptake. The pH 
effect that they proposed should have minimal 
effect in the clinically relevant pH range around 
7.4. 
Under the present experimental conditions, 
the capacity of the Scimed membrane for fen- 
tanyl is enormous (Table 5). To calculate the 
amount of fentanyl required to saturate the 
oxygenator, the membrane surface area in cm2 x 
130 ng is multiplied. The standard adult Scimed 
membrane oxygenator (model 3500-2A) with a 
surface area of 3.5 m2 would require >4.5 mg of 
fentanyl. In addition, the desired plasma concen- 
tration must be achieved in the priming solution. 
When patients are believed to need additional 
anesthesia, the technique of adding small 
amounts of fentanyl to the unsaturated CPB 
apparatus would have less effect than expected 
because the membrane is capable of absorbing 
most of the dose on the first pass. 
Although this study identified two signifi- 
cant factors which modify the in-vitro fentanyl 
interaction, fentanyl concentration and fluid 
motion, more variables need to be examined 
before these results are applied to the clinical 
setting. Potential modifiers of this interaction 
include the protein content of the CPB prime 
solution, the use of blood cells and/or plasma, 
temperature, pH, and concurrently administered 
drug interactions. One important issue is the 
nature of the interaction with regard to revers- 
Table 6. Predicted Fentanyl Absorption of Various Scimed 
Membranes by Size 
SUrfaCe Patient Predicted Fentanyl 
Model No. Area (In’) Weight (kg) Absorptive Capacity (mg) 
0400-2A 0.4 Upto 0.52 
OBOO-2A 0.8 upto 11 1.04 
1500-2A 1.5 12-19 1.95 
2500-2A 2.5 20-70 3.25 
3500-2A 3.5 71-95 4.55 
4500-2A 4.5 >96 5.65 
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ibility. Can fentanyl bound to the membrane in a 
clear priming solution be removed by subsequent 
mixing with the patient’s blood? Through future 
consideration of these unknown variables, it may 
be possible to refine the study technique further 
and increase clinical applications. It is recog- 
nized that many changes occur when CPB is 
initiated. Because of the complexity of the inter- 
action, a model that can examine all of the 
patient-membrane interaction has not been pos- 
sible to develop. It is hoped that by understand- 
ing the component parts, it may be possible to 
approach this model. 
Although fentanyl binding on Scimed 
membranes is noted in the current and previous 
studies, utilization of other membrane brands of 
different structure and/or composition may not 
produce the same results. The present techniques 
can be applied to examination of other mem- 
brane brands with similar sheetlike structure. 
Modification of the method will be necessary to 
study membranes with different structural form. 
In conclusion, it has been demonstrated 
that the Scimed silicone-based membrane is 
capable of rapidly absorbing a considerable 
quantity of fentanyl. The membrane continues to 
absorb fentanyl until it is saturated. In this study, 
two factors that influence this interaction were 
identifed. The rate of absorption is dependent on 
the fentanyl concentration available in the solu- 
tion and on circulation of the solution. When 
suprasaturated priming solutions are used, the 
capacity for fentanyl uptake is not altered by 
these factors. Saturation appears to be reached 
at -130 ng/cm2 for the intact and isolated 
Scimed membrane. An isolated membrane 
model was developed that accurately reflects the 
capacity of the intact membrane for fentanyl 
binding. When the isolated priming solution is 
stirred, a condition that mimics circulation of the 
prime through the CPB circuit, the resultant 
kinetics of uptake also correlate. The cost 
incurred when the intact bypass circuit is primed 
with radiolabeled drug is high. The isolated 
membrane model is a means of studying mem- 
brane interaction characteristics that efficiently 
conserve experimental supplies and funds. It is 
planned to use this model to explore the charac- 
teristics of other membrane brands, different 
drug interactions, and variations in the priming 
solution. The simplification of fentanyl mem- 
brane interactions and study of individual vari- 
ables will, hopefully, lead to a better understand- 
ing of the well-described clinical phenomenon. 
Development of a laboratory model applicable to 
a wide variety of clinical situations is the ulti- 
mate goal. 
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